These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 8274440)
1. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems. Katzenellenbogen BS; Bhardwaj B; Fang H; Ince BA; Pakdel F; Reese JC; Schodin D; Wrenn CK J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):39-48. PubMed ID: 8274440 [TBL] [Abstract][Full Text] [Related]
2. William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action. Katzenellenbogen BS; Fang H; Ince BA; Pakdel F; Reese JC; Wooge CH; Wrenn CK Breast Cancer Res Treat; 1993; 27(1-2):17-26. PubMed ID: 8260727 [TBL] [Abstract][Full Text] [Related]
3. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands. Reese JC; Katzenellenbogen BS J Biol Chem; 1991 Jun; 266(17):10880-7. PubMed ID: 2040605 [TBL] [Abstract][Full Text] [Related]
4. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor. Pakdel F; Reese JC; Katzenellenbogen BS Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756 [TBL] [Abstract][Full Text] [Related]
5. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652 [TBL] [Abstract][Full Text] [Related]
6. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965 [TBL] [Abstract][Full Text] [Related]
7. Identification of two cysteines closely positioned in the ligand-binding pocket of the human estrogen receptor: roles in ligand binding and transcriptional activation. Reese JC; Wooge CH; Katzenellenbogen BS Mol Endocrinol; 1992 Dec; 6(12):2160-6. PubMed ID: 1491695 [TBL] [Abstract][Full Text] [Related]
8. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination. Pakdel F; Katzenellenbogen BS J Biol Chem; 1992 Feb; 267(5):3429-37. PubMed ID: 1737796 [TBL] [Abstract][Full Text] [Related]
9. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. McInerney EM; Katzenellenbogen BS J Biol Chem; 1996 Sep; 271(39):24172-8. PubMed ID: 8798658 [TBL] [Abstract][Full Text] [Related]
10. Cysteine 530 of the human estrogen receptor alpha is the main covalent attachment site of 11beta-(aziridinylalkoxyphenyl)estradiols. Aliau S; Mattras H; Richard E; Borgna JL Biochemistry; 1999 Nov; 38(45):14752-62. PubMed ID: 10555957 [TBL] [Abstract][Full Text] [Related]
11. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens. Ince BA; Montano MM; Katzenellenbogen BS Mol Endocrinol; 1994 Oct; 8(10):1397-406. PubMed ID: 7531820 [TBL] [Abstract][Full Text] [Related]
12. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells. Weaver CA; Springer PA; Katzenellenbogen BS Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749 [TBL] [Abstract][Full Text] [Related]
13. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351. MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635 [TBL] [Abstract][Full Text] [Related]
14. Powerful dominant negative mutants of the human estrogen receptor. Ince BA; Zhuang Y; Wrenn CK; Shapiro DJ; Katzenellenbogen BS J Biol Chem; 1993 Jul; 268(19):14026-32. PubMed ID: 8314770 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways. Katzenellenbogen BS J Soc Gynecol Investig; 2000; 7(1 Suppl):S33-7. PubMed ID: 10732327 [TBL] [Abstract][Full Text] [Related]
17. Antiestrogens: mechanisms and actions in target cells. Katzenellenbogen BS; Montano MM; Le Goff P; Schodin DJ; Kraus WL; Bhardwaj B; Fujimoto N J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):387-93. PubMed ID: 7626486 [TBL] [Abstract][Full Text] [Related]
18. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465 [TBL] [Abstract][Full Text] [Related]
19. Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor. Harlow KW; Smith DN; Katzenellenbogen JA; Greene GL; Katzenellenbogen BS J Biol Chem; 1989 Oct; 264(29):17476-85. PubMed ID: 2793867 [TBL] [Abstract][Full Text] [Related]
20. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites. Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]